SCHEMBL29081502

SCHEMBL29081502

CC1CNC(c2ccc(F)c(F)c2)CC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.33
ADRA2C P18825 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
HTR7 P34969 2/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
CREBBP Q92793 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
P2RX7 Q99572 1/20 0.32
GRIA4 P48058 1/20 0.32
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
TSHR P16473 1/20 0.31
KDM1A O60341 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24365538 1.00 CHRNB2 (0.33) CHRNB2ADRA2CCHRNB4CHRNA3CHRNA7
SCHEMBL29081504 1.00 CHRNB2 (0.33) CHRNB2ADRA2CCHRNB4CHRNA3CHRNA7
SCHEMBL30469672 0.83 TDP1 (0.38) SMN1; SMN2
SCHEMBL29081223 0.83 TDP1 (0.38) SMN1; SMN2
SCHEMBL29081225 0.83 TDP1 (0.38) SMN1; SMN2
SCHEMBL29324205 0.83 TDP1 (0.38) SMN1; SMN2
SCHEMBL24364911 0.78 SLC6A3 (0.48) TSHRKDM1A
SCHEMBL29081943 0.76 ALDH1A1 (0.46) SMN1; SMN2TSHR
SCHEMBL30470609 0.76 ALDH1A1 (0.46) SMN1; SMN2TSHR
SCHEMBL29081944 0.76 ALDH1A1 (0.46) SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116568677-A piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers 探戈医药股份有限公司 2023-08-08 CN disclosed